Condition: Neuromuscular Blocks · Sponsor: The Cleveland Clinic
The investigators propose a single-center, assessor-Blinded, parallel group randomized trial to compare the efficacy of reversal of rocuronium induced neuromuscular blockade by sugammadex versus neostigmine in patients undergoing Endoscopic retrograde cholangiopancreatography at Cleveland Clinic Fairview Hospital.
This description comes directly from the study's public registry record.
Sabry Ayad, MD · 216-476-7052 · Saayad@ccf.org
Erica Linna, RN · 216-633-5073 · Linnae@ccf.org
Always discuss trial participation with your own doctor first.
| Cleveland Clinic Fairview Hospital | Cleveland, Ohio, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06136585